Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.200
-0.010 (-0.83%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Phio Pharmaceuticals Employees
Phio Pharmaceuticals had 6 employees as of December 31, 2025. The number of employees increased by 1 or 20.00% compared to the previous year.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$1,449,667
Market Cap
13.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioCardia | 21 |
| Moleculin Biotech | 17 |
| IN8bio | 17 |
| Soligenix | 14 |
| Intensity Therapeutics | 7 |
| CDT Equity | 6 |
| Jupiter Neurosciences | 5 |
| Kairos Pharma | 4 |
PHIO News
- 13 days ago - Phio Pharmaceuticals Transcript: Fireside chat - Transcripts
- 14 days ago - Phio Pharmaceuticals Transcript: Second Annual Centri Capital Conference - Transcripts
- 15 days ago - Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026 - Newsfile Corp
- 4 weeks ago - Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762 - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement - Newsfile Corp
- 6 weeks ago - Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office - Newsfile Corp
- 6 weeks ago - Phio Pharmaceuticals Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 7 weeks ago - Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT - GlobeNewsWire